ALMUNDA PRO NV And 5 Other Stocks Have Very High Payout Ratio

(VIANEWS) – ALMUNDA PRO NV (AMUND.AS), CAIRN HOMES PLC (C5H.IR), CEGEDIM (CGM.PA) are the highest payout ratio stocks on this list.

Here’s the data we’ve collected of stocks with a high payout ratio up until now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to distribute them.

When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. ALMUNDA PRO NV (AMUND.AS)

239.91% Payout Ratio

Almunda Professionals N.V., a business and IT consultancy company, provides business services in the financial sector. It offers consultancy services in the areas of regulatory change, digital transformation, information security, and information services. The company was formerly known as Novisource N.V. and changed its name to Almunda Professionals N.V. in August 2021. Almunda Professionals N.V. was founded in 2001 and is based in Amsterdam, the Netherlands.

Earnings Per Share

As for profitability, ALMUNDA PRO NV has a trailing twelve months EPS of €0.02.

PE Ratio

ALMUNDA PRO NV has a trailing twelve months price to earnings ratio of 65.5. Meaning, the purchaser of the share is investing €65.5 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.17%.

Volume

Today’s last reported volume for ALMUNDA PRO NV is 104 which is 97.84% below its average volume of 4827.

Yearly Top and Bottom Value

ALMUNDA PRO NV’s stock is valued at €1.31 at 02:10 EST, way under its 52-week high of €1.60 and way above its 52-week low of €1.17.

Revenue Growth

Year-on-year quarterly revenue growth grew by 101.9%, now sitting on 26.26M for the twelve trailing months.

More news about ALMUNDA PRO NV.

2. CAIRN HOMES PLC (C5H.IR)

50.88% Payout Ratio

Cairn Homes plc operates as a homebuilder in Ireland. It is involved in the development and sale of residential properties, as well as rental of properties. The company was incorporated in 2014 and is based in Dublin, Ireland.

Earnings Per Share

As for profitability, CAIRN HOMES PLC has a trailing twelve months EPS of €0.11.

PE Ratio

CAIRN HOMES PLC has a trailing twelve months price to earnings ratio of 10. Meaning, the purchaser of the share is investing €10 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.59%.

Volume

Today’s last reported volume for CAIRN HOMES PLC is 22267 which is 96.89% below its average volume of 717811.

Dividend Yield

As claimed by Morningstar, Inc., the next dividend payment is on Apr 20, 2023, the estimated forward annual dividend rate is 0.06 and the estimated forward annual dividend yield is 5.44%.

Moving Average

CAIRN HOMES PLC’s worth is under its 50-day moving average of €1.10 and way higher than its 200-day moving average of €1.00.

More news about CAIRN HOMES PLC.

3. CEGEDIM (CGM.PA)

50% Payout Ratio

Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals in France, other European countries, and internationally. It operates in two segments, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services segment markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This segment also provides solutions for hosting, HR and payroll management outsourcing, electronic data exchange, and data processing services. The Healthcare Professionals division sells management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.

Earnings Per Share

As for profitability, CEGEDIM has a trailing twelve months EPS of €0.98.

PE Ratio

CEGEDIM has a trailing twelve months price to earnings ratio of 22.45. Meaning, the purchaser of the share is investing €22.45 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.5%.

Yearly Top and Bottom Value

CEGEDIM’s stock is valued at €22.00 at 02:10 EST, below its 52-week high of €23.55 and way above its 52-week low of €13.56.

More news about CEGEDIM.

4. YARA INTERNATIONAL (YAR.OL)

41.92% Payout Ratio

Yara International ASA provides crop nutrition and industrial solutions in Norway, European Union, Europe, Africa, Asia, North and Latin America, Australia, and New Zealand. The company offers ammonium- and urea-based fertilizers; compound fertilizers that contain plant nutrients, such as nitrogen, phosphorus, and potassium; coatings; biostimulants; organic-based fertilizers; green fertilizers are nitrate-based mineral fertilizers, as well as foliar and fertigation solutions; and nitrate, calcium nitrate, micronutrient, and fertigation fertilizers. It also offers digital solutions, such as variable rate application solutions; N-Sensor, a tractor-mounted hardware; N-Tester, a hand held nitrogen measurement tool; and Atfarm, a digital toolbox for farmer. The company sells its products under YaraBela, YaraMila, YaraLiva, YaraVita, YaraRega, YaraTera, YaraSuna, and YaraVera and brands. Yara International ASA was founded in 1905 and is headquartered in Oslo, Norway.

Earnings Per Share

As for profitability, YARA INTERNATIONAL has a trailing twelve months EPS of kr38.39.

PE Ratio

YARA INTERNATIONAL has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing kr10.5 for every norwegian krone of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.01%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 13, 2023, the estimated forward annual dividend rate is 55 and the estimated forward annual dividend yield is 12.92%.

Yearly Top and Bottom Value

YARA INTERNATIONAL’s stock is valued at kr403.10 at 02:10 EST, way below its 52-week high of kr497.40 and higher than its 52-week low of kr370.40.

Sales Growth

YARA INTERNATIONAL’s sales growth is negative 26.2% for the ongoing quarter and negative 18.4% for the next.

More news about YARA INTERNATIONAL.

5. BOIRON (BOI.PA)

32.87% Payout Ratio

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sédatif PC to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Earnings Per Share

As for profitability, BOIRON has a trailing twelve months EPS of €2.9.

PE Ratio

BOIRON has a trailing twelve months price to earnings ratio of 17.24. Meaning, the purchaser of the share is investing €17.24 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.13%.

Volume

Today’s last reported volume for BOIRON is 5861 which is 60.25% below its average volume of 14748.

Moving Average

BOIRON’s value is way above its 50-day moving average of €40.72 and way higher than its 200-day moving average of €43.14.

More news about BOIRON.

6. HOME INVEST BE. (HOMI.BR)

30.83% Payout Ratio

Home Invest Belgium S.A. operates as a real estate investment company in Belgium. It primarily invests in residential properties. As of December 31, 2008, the company's real estate portfolio consisted of 992 rental units with a total rentable space of approximately 111,091 square meters. The company was formerly known as Home Invest and changed its name to Home Invest Belgium S.A. in May 1999. Home Invest Belgium S.A. was founded in 1980 and is based in Brussels, Belgium.

Earnings Per Share

As for profitability, HOME INVEST BE. has a trailing twelve months EPS of €3.3.

PE Ratio

HOME INVEST BE. has a trailing twelve months price to earnings ratio of 5.13. Meaning, the purchaser of the share is investing €5.13 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.2%.

Yearly Top and Bottom Value

HOME INVEST BE.’s stock is valued at €16.92 at 02:10 EST, way under its 52-week high of €29.53 and way above its 52-week low of €15.30.

Revenue Growth

Year-on-year quarterly revenue growth declined by 6.2%, now sitting on 36.6M for the twelve trailing months.

Volume

Today’s last reported volume for HOME INVEST BE. is 4011 which is 65.01% below its average volume of 11466.

Moving Average

HOME INVEST BE.’s worth is under its 50-day moving average of €17.59 and way under its 200-day moving average of €20.51.

More news about HOME INVEST BE..

Leave a Reply

Your email address will not be published. Required fields are marked *